To further explore on- and off-label use of these drugs, Avalere Health evaluated 20182023 commercial (42% population sample), Medicare fee-for-service (FFS) (100%), Medicare Advantage (25%), and Managed Medicaid (69%) pharmacy claims data to identify beneficiaries with a pharmacy drug claim for GLP-1 and/or GIP/GLP-1 RAs
However, patients with conditions requiring fluid restriction (such as heart failure or advanced kidney disease) should follow their healthcare provider's specific guidance regarding fluid intake
Insulin Resistance (Over Time) Chronic use may disrupt natural insulin signaling, leading to glucose metabolism issues
Likewise, Wegovy is priced at $1,349.02 every 28 days, no matter whether the weekly injections contain 0.25, 0.5, 1, 1.7 or 2.4 mg of semaglutide
Patients with pre-existing diabetic retinopathy should maintain regular ophthalmology follow-up